Nexecaine: Composition, Risks, Research Status and Safety Information

Nexecaine is not a standard approved pharmaceutical medicine, it is a name for a novel psychoactive substance mixture. Very little is known about Nexecaine and the composition may vary from product to product. Thus, it is not safe to assume that products marketed under that name are all formulated the same, or that they will have predictable effects.

What Is Nexecaine?

NexCaine has been mentioned in relation to research chemicals and new psychoactive substances. It is described in published databases as a mixture of N-ethylhexedrone (HEX-EN) and benzocaine. N-ethylhexedrone is a synthetic cathinone and benzocaine is a local anaesthetic.

But previous accounts of Nexecaine have claimed that its precise composition was never publicly revealed. This uncertainty complicates the accurate determination of the chemical characteristics, potency or safety profile of a particular sample.

Reported Components

The composition as known from published sources is:

• N-ethylhexedrone (HEX-EN) : A synthetic cathinone that has been linked to stimulant-type psychoactive effects.
• Benzocaine: Used as a local anaesthetic in some topical and oral preparations.

Importantly, these reports should not be taken as evidence that each product labelled Nexecaine contains exactly the same ingredients or concentrations.

What Is Nexecaine Classified As?

Nexecaine has been included in the studies on new psychoactive substances (NPS). In a scientific survey of online research-chemical markets, Nexecaine was one of the substances related to synthetic cathinones.

So Nexecaine should not be confused as a treatment approved for any pain, anxiety, depression or other medical condition. Being in research-chemical databases doesn’t prove it works medically, either.

Why is its composition important?

The main problem is uncertainty. When a mixture has an undisclosed or variable formulation, users may not know what active chemicals are present in the sample, nor how much of each chemical is present.

Moreover, effects from synthetic cathinones are unpredictable especially if their identity, concentration or purity has not been independently verified. Also, mixing psychoactive compounds can be more dangerous.

Possible health and safety issues

Nexecaine is not a pharmaceutical standard, so the effects and risks cannot be reliably predicted by name only.

Synthetic cathinones are associated with stimulation, increased heart rate and blood pressure, agitation, anxiety, insomnia, confusion and other adverse reactions. In emergencies medical attention may be needed.

In addition, benzocaine can cause adverse reactions in sensitive persons. Therefore, benzocaine is not a medically approved component for a psychoactive mixture.

Why You Should Seek Professional Help

People who see a product advertized as Nexecaine should not think that it is the same as a prescription drug or an over-the-counter drug. And they should know the uncertainty of what it is and what it’s made of.

If someone experiences severe agitation, chest pain, difficulty breathing, loss of consciousness, seizures, or any other serious reaction after exposure, they need to get immediate medical help.

Nexecaine Research Status

Nexecaine has been studied by researchers of the emerging psychoactive substances. However, there is very little reliable information on its standardised formulation, long term effects, pharmacology and clinical safety.

Therefore, researchers should not use the commercial descriptions as a reference but should refer to the validated analytical information, the proper laboratory procedures and the relevant institutional and legal requirements.

Conclusion:

Nexecaine is a poorly characterised psychoactive mixture related to N-ethylhexedrone and benzocaine, according to available sources. Its composition is said to be variable or undisclosed, making it difficult to predict its effects and safety.

That is the reason why Nexecaine should not be marketed as a medicine or dietary supplement that has been established. For novel psychoactive substances, correct identification, independent analytical testing, proper laboratory controls, and knowledge of relevant regulations are important.